CF
OPRX icon

Corebridge Financial’s OptimizeRx OPRX Stock Holding History

Corebridge Financial’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,719
Closed -$75.5K – 1926
2025
Q1 		$75.5K Sell
8,719
-15
-0.2% -$92 ﹤0.01% 2583
2024
Q4 		$42.4K Sell
8,734
-659
-7% -$3.68K ﹤0.01% 2862
2024
Q3 		$72.5K Sell
9,393
-58
-0.6% -$516 ﹤0.01% 2754
2024
Q2 		$94.5K Buy
+9,451
New +$104K ﹤0.01% 2628

Other funds holding OPRX

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $302M AUM 117.41% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Corebridge Financial's OPRX Position: Q2 2025 in Review

Corebridge Financial sold out of OptimizeRx (OPRX) in Q2 2025, closing a stake of 8,719 shares — an estimated $75.5K sold.

Corebridge Financial first reported a position in OPRX in Q2 2024 and held it in 4 quarters. The position peaked at $94.5K in Q2 2024. 110 funds tracked by Wall St. Rank hold OPRX as of Q2 2025.

  • Corebridge Financial reported no remaining OptimizeRx position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 8,719 OptimizeRx shares in Q2 2025, an estimated $75.5K.
  • Corebridge Financial first reported a position in OptimizeRx in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's OptimizeRx position peaked at $94.5K in Q2 2024.
  • 110 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.